Cargando…
Blood Pressure and Chronic Kidney Disease Progression: An Updated Review
Hypertension (HTN) is common in chronic kidney disease (CKD), and it may aggravate CKD progression. The optimal blood pressure (BP) value in CKD patients is not established yet, although systolic BP ≤130 mmHg is acceptable as a target. Continuous BP monitoring is essential to detect the different va...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116515/ https://www.ncbi.nlm.nih.gov/pubmed/35602805 http://dx.doi.org/10.7759/cureus.24244 |
_version_ | 1784710127851405312 |
---|---|
author | Habas, Elmukhtar Habas, Eshrak Khan, Fahmi Y Rayani, Amnna Habas, Aml Errayes, Mehdi Farfar, Khalifa L Elzouki, Abdel-Naser Y |
author_facet | Habas, Elmukhtar Habas, Eshrak Khan, Fahmi Y Rayani, Amnna Habas, Aml Errayes, Mehdi Farfar, Khalifa L Elzouki, Abdel-Naser Y |
author_sort | Habas, Elmukhtar |
collection | PubMed |
description | Hypertension (HTN) is common in chronic kidney disease (CKD), and it may aggravate CKD progression. The optimal blood pressure (BP) value in CKD patients is not established yet, although systolic BP ≤130 mmHg is acceptable as a target. Continuous BP monitoring is essential to detect the different variants of high BP and monitor the treatment response. Various methods of BP measurement in the clinic office and at home are currently used. One of these methods is ambulatory BP monitoring (ABPM), by which BP can be closely assessed for even diurnal changes. We conducted a non-systematic literature review to explore and update the association between high BP and the course of CKD and to review various BP monitoring methods to determine the optimal method for BP recording in CKD patients. PubMed, EMBASE, Google, Google Scholar, and Web Science were searched for published reviews and original articles on BP and CKD by using various phrases and keywords such as "hypertension and CKD", "CKD progression and hypertension", "CKD stage and hypertension", "BP control in CKD", "BP measurement methods", "diurnal BP variation effect on CKD progression", and "types of hypertension." We evaluated and discussed published articles relevant to the review objective. Before preparing the final draft of this article, each author was assigned a section of the topic to read, research deeply, and write a summary about the assigned section. Then a summary of each author's contribution was collected and discussed in several group sessions. Early detection of high BP is essential to prevent CKD development and progression. Although the latest Kidney Disease Improving Global Outcomes (KDIGO) guidelines suggest that a systolic BP ≤120 mmHg is the target toprevent CKD progression, systolic BP ≤130 mmHg is universally recommended.ABPM is a promising method to diagnose and follow up on BP control; however, the high cost of the new devices and patient unfamiliarity with them have proven to be major disadvantages with regard to this method. |
format | Online Article Text |
id | pubmed-9116515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-91165152022-05-20 Blood Pressure and Chronic Kidney Disease Progression: An Updated Review Habas, Elmukhtar Habas, Eshrak Khan, Fahmi Y Rayani, Amnna Habas, Aml Errayes, Mehdi Farfar, Khalifa L Elzouki, Abdel-Naser Y Cureus Internal Medicine Hypertension (HTN) is common in chronic kidney disease (CKD), and it may aggravate CKD progression. The optimal blood pressure (BP) value in CKD patients is not established yet, although systolic BP ≤130 mmHg is acceptable as a target. Continuous BP monitoring is essential to detect the different variants of high BP and monitor the treatment response. Various methods of BP measurement in the clinic office and at home are currently used. One of these methods is ambulatory BP monitoring (ABPM), by which BP can be closely assessed for even diurnal changes. We conducted a non-systematic literature review to explore and update the association between high BP and the course of CKD and to review various BP monitoring methods to determine the optimal method for BP recording in CKD patients. PubMed, EMBASE, Google, Google Scholar, and Web Science were searched for published reviews and original articles on BP and CKD by using various phrases and keywords such as "hypertension and CKD", "CKD progression and hypertension", "CKD stage and hypertension", "BP control in CKD", "BP measurement methods", "diurnal BP variation effect on CKD progression", and "types of hypertension." We evaluated and discussed published articles relevant to the review objective. Before preparing the final draft of this article, each author was assigned a section of the topic to read, research deeply, and write a summary about the assigned section. Then a summary of each author's contribution was collected and discussed in several group sessions. Early detection of high BP is essential to prevent CKD development and progression. Although the latest Kidney Disease Improving Global Outcomes (KDIGO) guidelines suggest that a systolic BP ≤120 mmHg is the target toprevent CKD progression, systolic BP ≤130 mmHg is universally recommended.ABPM is a promising method to diagnose and follow up on BP control; however, the high cost of the new devices and patient unfamiliarity with them have proven to be major disadvantages with regard to this method. Cureus 2022-04-18 /pmc/articles/PMC9116515/ /pubmed/35602805 http://dx.doi.org/10.7759/cureus.24244 Text en Copyright © 2022, Habas et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Habas, Elmukhtar Habas, Eshrak Khan, Fahmi Y Rayani, Amnna Habas, Aml Errayes, Mehdi Farfar, Khalifa L Elzouki, Abdel-Naser Y Blood Pressure and Chronic Kidney Disease Progression: An Updated Review |
title | Blood Pressure and Chronic Kidney Disease Progression: An Updated Review |
title_full | Blood Pressure and Chronic Kidney Disease Progression: An Updated Review |
title_fullStr | Blood Pressure and Chronic Kidney Disease Progression: An Updated Review |
title_full_unstemmed | Blood Pressure and Chronic Kidney Disease Progression: An Updated Review |
title_short | Blood Pressure and Chronic Kidney Disease Progression: An Updated Review |
title_sort | blood pressure and chronic kidney disease progression: an updated review |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116515/ https://www.ncbi.nlm.nih.gov/pubmed/35602805 http://dx.doi.org/10.7759/cureus.24244 |
work_keys_str_mv | AT habaselmukhtar bloodpressureandchronickidneydiseaseprogressionanupdatedreview AT habaseshrak bloodpressureandchronickidneydiseaseprogressionanupdatedreview AT khanfahmiy bloodpressureandchronickidneydiseaseprogressionanupdatedreview AT rayaniamnna bloodpressureandchronickidneydiseaseprogressionanupdatedreview AT habasaml bloodpressureandchronickidneydiseaseprogressionanupdatedreview AT errayesmehdi bloodpressureandchronickidneydiseaseprogressionanupdatedreview AT farfarkhalifal bloodpressureandchronickidneydiseaseprogressionanupdatedreview AT elzoukiabdelnasery bloodpressureandchronickidneydiseaseprogressionanupdatedreview |